Progressive Supranuclear Palsy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Conditions: Corticobasal Degeneration (CBD); Corticobasal Syndrome (CBS); Cortical-basal Ganglionic Degeneration (CBGD); Progressive Supranuclear Palsy (PSP); Nonfluent Variant Primary Progressive Aphasia (nfvPPA); Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP) Intervention: Other: Observational Study Sponsors: University of California, San Francisco; National Institutes of Health (NIH); National Institute on Aging (NIA) Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2016 Category: Research Source Type: clinical trials
Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy
< b > Condition < /b > : Progressive Supranuclear Palsy (PSP) < br/ > < b > Interventions < /b > : Drug: Rivastigmine; Drug: Placebo < br/ > < b > Sponsor < /b > : Assistance Publique Hopitaux De Marseille < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2016 Category: Research Source Type: clinical trials
